Kimia Biosciences logo

Kimia Biosciences

KIMIABIOSCIENCESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹135 Cr
Volatility
Moderate
P/E Ratio
19.4
EBITDA
₹14.26 Cr
Return on Equity
96.45%
Debt to Equity
1.94
Book Value
₹3.75
EPS
₹0
52W High
₹43.28
52W Low
₹23.2

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has a good return on equity (ROE) track record: 3 Years ROE 53.6%

Weaknesses

4
  • Stock is trading at 7.37 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.84% over past five years.
  • Tax rate seems low

Growth Rate

Revenue Growth
-4.43% lower than 3Y
Net Income Growth
-11.87% lower than 3Y
Cash Flow Change
46.66% lower than 3Y
ROE
-106% higher than 3Y
ROCE
-986% lower than 3Y
EBITDA Margin (Avg.)
-31.77%

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
24.23
24.2
26.14
30.3
22.4
28.18
30.1
38.24
23.58
34
30.1
27.2
20.72
Expenses
25.87
26.16
27.19
26.14
18.69
24.81
25.1
30.06
21.05
31.48
23.54
24.54
18.37
Operating Profit
-1.64
-1.96
-1.05
4.16
3.71
3.37
5
8.18
2.53
2.52
6.56
2.66
2.35
OPM %
-6.77%
-8.1%
-4.02%
13.73%
16.56%
11.96%
16.61%
21.39%
10.73%
7.41%
21.79%
9.78%
11.34%
Other Income
0.13
0.64
0.58
0.3
0.08
0.37
0.42
0.44
0.85
-0.33
0.1
1.01
0.08
Interest
1.28
1.12
1.31
1.34
1.11
1.04
1.01
1.4
1.75
0.27
0.75
0.75
0.83
Depreciation
0.83
0.82
0.82
0.82
0.9
0.79
0.82
0.88
0.94
0.97
0.85
1.16
1.11
PBT
-3.62
-3.26
-2.6
2.3
1.78
1.91
3.59
6.34
0.69
0.95
5.06
1.76
0.49
Tax %
-25.14%
-25.15%
-25%
22.17%
19.66%
15.71%
-27.3%
68.61%
13.04%
-7.37%
-7.71%
78.98%
26.53%
Net Profit
-2.71
-2.44
-1.95
1.8
1.44
1.61
4.57
1.99
0.6
1.02
5.44
0.37
0.36
EPS in Rs
-0.57
-0.52
-0.41
0.38
0.3
0.34
0.97
0.42
0.13
0.22
1.15
0.08
0.08
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2
0
1
76
94
106
133
125
129
105
119
115
112
Expenses
4
4
2
74
88
102
124
124
133
105
99
101
98
Operating Profit
-2
-3
-1
2
6
4
8
1
-5
0
20
14
14
OPM %
-110%
-1779%
-56%
3.2%
6%
4.2%
6%
0.5%
-3.9%
-0.5%
17%
12%
13%
Other Income
1
0
0
1
1
1
2
1
0
2
1
2
1
Interest
0
1
0
1
2
3
3
4
4
5
5
4
3
Depreciation
0
0
0
1
1
2
2
3
3
3
3
4
4
PBT
-2
-4
-1
2
4
1
6
-5
-12
-7
14
8
8
Tax %
1%
0%
-8%
-4%
-1%
-13%
8%
-26%
-25%
-26%
29%
12%
—
Net Profit
-2
-4
-1
2
4
1
5
-4
-9
-5
10
7
7
EPS in Rs
-2.3
-5.48
-1.26
2.26
2.64
0.3
1.08
-0.78
-1.98
-1.12
2.03
1.57
1.53
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
1
1
5
5
5
5
5
5
5
Reserves
-7
-11
-12
0
4
9
14
10
1
-4
5
13
Borrowings
1
7
14
34
31
34
45
41
53
44
33
35
Other Liabilities
4
1
3
22
29
38
43
54
63
56
68
51
Total Liabilities
5
4
12
58
65
86
107
109
121
100
111
103
Fixed Assets
3
3
7
13
16
18
28
35
34
32
33
37
CWIP
0
0
3
2
2
6
6
0
1
1
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1
1
2
43
48
62
72
74
87
68
78
66
Total Assets
5
4
12
58
65
86
107
109
121
100
111
103
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
-6
-1
-7
-3
0
6
8
-7
15
21
11
Investing
0
0
-6
-2
-2
-9
-14
-1
-3
-1
-5
-8
Financing
0
6
7
10
4
8
8
-8
10
-13
-17
-3
Net Cash Flow
0
0
0
0
0
0
0
0
0
0
0
0
Free Cash Flow
0
-6
-7
-10
-5
-9
-8
6
-10
13
17
3
CFO/OP
-2
177
85
-287
-45
5
71
1,281
136
-3,021
105
76
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
56
173
20
141
113
128
115
88
87
96
113
93
Inventory Days
50
319
615
59
83
92
89
146
183
149
178
137
Days Payable
667
91
511
120
91
121
116
159
177
194
260
220
Cash Conversion Cycle
-560
401
124
80
105
100
88
76
93
51
31
10
Working Capital Days
-530
-173
-1,358
48
62
73
53
31
16
-30
-22
5
ROCE %
-127%
-188%
-10%
10%
16%
9%
16%
-2%
-12%
-4%
42%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Kimia Biosciences insights

66 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

DIIs0.38%Promot.74.94%Others1.80%Public22.88%As ofJun 2026

Documents

Frequently Asked Questions about Kimia Biosciences

What does Kimia Biosciences Ltd do?
Incorporated in 1993, Kimia Biosciences Ltd is in the business of manufacturing and sale pharmaceutical products[1]
Where is Kimia Biosciences Ltd (530313) listed?
Kimia Biosciences Ltd trades as KIMIABIOSCIENCESLTD on the NSE and under code 530313 on the BSE.
Which sector does Kimia Biosciences Ltd belong to?
Kimia Biosciences Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Kimia Biosciences Ltd?
Kimia Biosciences Ltd has a market capitalisation of ₹135.39 Cr, which places it in the Small Cap band.
What is the PE ratio of Kimia Biosciences Ltd?
Kimia Biosciences Ltd trades at a PE ratio of 19.40, on earnings per share of ₹0, against a book value of ₹3.75 per share.
What is the 52-week high and low of Kimia Biosciences Ltd?
Over the last 52 weeks Kimia Biosciences Ltd has traded between ₹23.2 and ₹43.28.
What is the Return on Equity (ROE) of Kimia Biosciences Ltd?
Kimia Biosciences Ltd reported a return on equity of 96.45%. Its debt-to-equity ratio is 1.94.

Company Information

Incorporated in 1993, Kimia Biosciences Ltd is in the business of manufacturing and sale pharmaceutical products[1]

Website kimiabiosciences.com
CEO Mr. Sameer Goel
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530313.md for Kimia Biosciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List